Wytyczne leczenia cukrzycy 2009 – interpretacja nowych zaleceń Komentarz
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
wrz 30, 2009
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
##plugins.themes.bootstrap3.article.details##
Jak cytować
Simońska-Cichocka, E., & Gumprecht, J. (2009). Wytyczne leczenia cukrzycy 2009 – interpretacja nowych zaleceń. Medycyna Faktów , 2(3(4), 36-40. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2645
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. The Action to Control Cardiovascular Risk in Diabetes Study Group. N. Engl. J. Med. 2008; 358: 2545-2559.
2. ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patient with type 2 diabetes. N. Engl. J. Med. 2008; 358: 2560-2572.
3. Duckworth W. et al. (VADT study group): Intensive glucose control and complications in American veterans with type 2 diabetes. NEJM 2009; 360: 129-139.
4. Holman R. et al.: 10-year follow up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008; 358: 2577-2589.
5. ESC/EHS Guidelines 2007. Eur. Heart J. 2007; 28: 1462-1536.
6. Hartweg J. et al.: Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia 2007; 50: 1593-1602.
2. ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patient with type 2 diabetes. N. Engl. J. Med. 2008; 358: 2560-2572.
3. Duckworth W. et al. (VADT study group): Intensive glucose control and complications in American veterans with type 2 diabetes. NEJM 2009; 360: 129-139.
4. Holman R. et al.: 10-year follow up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008; 358: 2577-2589.
5. ESC/EHS Guidelines 2007. Eur. Heart J. 2007; 28: 1462-1536.
6. Hartweg J. et al.: Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia 2007; 50: 1593-1602.